These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18161631)

  • 1. In vitro release--in vivo microbiological and toxicological studies on ketoconazole lipid granules.
    Ozyazici M; Gokce EH; Ozer O; Ay Z; Guneri T; Ertan G; Gokce G; Metin DY; Hilmioglu S; Durmaz G; Yalcin A; Pekcetin C; Ozyurt D
    Pharm Dev Technol; 2007; 12(6):581-90. PubMed ID: 18161631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of ketoconazole gel-flakes in treatment of vaginal candidiasis: Formulation, in vitro and clinical evaluation.
    Abd Ellah NH; Abdel-Aleem JA; Abdo MN; Abou-Ghadir OF; Zahran KM; Hetta HF
    Int J Pharm; 2019 Aug; 567():118472. PubMed ID: 31252146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida albicans.
    Karasulu HY; Hilmioğlu S; Metin DY; Güneri T
    Farmaco; 2004 Feb; 59(2):163-7. PubMed ID: 14871509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pharmacotechnical design on the in vitro interaction of ketoconazole tablets with non-systemic antacids.
    Córdoba-Díaz D; Córdoba-Díaz M; Awad S; Córdoba-Borrego M
    Int J Pharm; 2001 Sep; 226(1-2):61-8. PubMed ID: 11532571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole.
    Kakkar S; Karuppayil SM; Raut JS; Giansanti F; Papucci L; Schiavone N; Kaur IP
    Int J Pharm; 2015 Nov; 495(1):276-289. PubMed ID: 26325312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-Linked Fluorescent Supramolecular Nanoparticles for Intradermal Controlled Release of Antifungal Drug-A Therapeutic Approach for Onychomycosis.
    Wang F; Yang P; Choi JS; Antovski P; Zhu Y; Xu X; Kuo TH; Lin LE; Kim DNH; Huang PC; Xu H; Lee CF; Wang C; Hsu CC; Chen K; Weiss PS; Tseng HR
    ACS Nano; 2018 Jul; 12(7):6851-6859. PubMed ID: 29851454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of formulation and process variables on lipid based sustained release tablets via continuous twin screw granulation: A comparative study.
    Kallakunta VR; Tiwari R; Sarabu S; Bandari S; Repka MA
    Eur J Pharm Sci; 2018 Aug; 121():126-138. PubMed ID: 29772273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface-modified mucoadhesive microgels as a controlled release system for miconazole nitrate to improve localized treatment of vulvovaginal candidiasis.
    Kenechukwu FC; Attama AA; Ibezim EC; Nnamani PO; Umeyor CE; Uronnachi EM; Gugu TH; Momoh MA; Ofokansi KC; Akpa PA
    Eur J Pharm Sci; 2018 Jan; 111():358-375. PubMed ID: 28986195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the lubricant performance of Compritol HD5 ATO and Compritol 888 ATO: effect of polyethylene glycol behenate on lubricant capacity.
    N'Diaye A; Jannin V; Bérard V; Andrès C; Pourcelot Y
    Int J Pharm; 2003 Mar; 254(2):263-9. PubMed ID: 12623202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of multiple dosing of ketoconazole on pharmacokinetics of midazolam, a cytochrome P-450 3A substrate in beagle dogs.
    Kuroha M; Azumano A; Kuze Y; Shimoda M; Kokue E
    Drug Metab Dispos; 2002 Jan; 30(1):63-8. PubMed ID: 11744613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets.
    Roberts M; Vellucci D; Mostafa S; Miolane C; Marchaud D
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1068-76. PubMed ID: 22149472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-beta-cyclodextrin.
    Taneri F; Ozcan I; Guneri T
    Drug Deliv; 2010 Apr; 17(3):152-7. PubMed ID: 20148713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hot-melt coating technology. I. Influence of Compritol 888 Ato and granule size on theophylline release.
    Faham A; Prinderre P; Farah N; Eichler KD; Kalantzis G; Joachim J
    Drug Dev Ind Pharm; 2000 Feb; 26(2):167-76. PubMed ID: 10697753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating effect of microemulsion components: In vitro permeation of ketoconazole.
    Patel MR; Patel RB; Parikh JR; Solanki AB; Patel BG
    Pharm Dev Technol; 2011 Jun; 16(3):250-8. PubMed ID: 20146553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals.
    Aburahma MH; Badr-Eldin SM
    Expert Opin Drug Deliv; 2014 Dec; 11(12):1865-83. PubMed ID: 25152197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin-Loaded Liquid Crystalline Systems for Controlled Drug Release and Improved Treatment of Vulvovaginal Candidiasis.
    Rodero CF; Fioramonti Calixto GM; Cristina Dos Santos K; Sato MR; Aparecido Dos Santos Ramos M; Miró MS; Rodríguez E; Vigezzi C; Bauab TM; Sotomayor CE; Chorilli M
    Mol Pharm; 2018 Oct; 15(10):4491-4504. PubMed ID: 30184431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative omics analyses of hepatotoxicity induced by oral azole drugs in mice liver and primary hepatocytes.
    Park SM; Kang SJ; Choi MS; Kim S; Yoon S; Oh JH
    Toxicol Mech Methods; 2019 Sep; 29(7):531-541. PubMed ID: 31099283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compritol®888 ATO a lipid excipient for sustained release of highly water soluble active: formulation, scale-up and IVIVC study.
    Patere SN; Desai NS; Jain AS; Kadam PP; Thatte UM; Gogtay N; Kapadia CJ; Farah N; Nagarsenker MS
    Curr Drug Deliv; 2013 Oct; 10(5):548-56. PubMed ID: 23607649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nizoral - an effective and affordable drug to treat vaginal candidiasis ].
    Nikolov A
    Akush Ginekol (Sofiia); 2009; 48 Suppl 1():44-7. PubMed ID: 20387276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.